PlainPill

Enclomiphene

Also known as Enclomiphene Citrate

The short answer. More people than not who report on Enclomiphene say it helped (59% of 191). It is most often used for hormones: 90% of 138 reports say that improved. There is a moderate body of research — 2 meta-analyses and 3 trials. The most common complaint is eye floaters.

What users report
59%helped191 reports · high confidence
113 helped62 mixed17 didn't help

From 563 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
BModerate research base
2
meta-analyses
3
RCTs
82
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Enclomiphene does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

BModerate research base

At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 2 meta-analyses on PubMed ↗ · 3 randomized trials ↗

Arch Endocrinol Metab · 2025 · Meta-analysis / systematic review
Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials

Conclusion: SERM therapy is associated with significantly improved levels of TT, LH, and FSH in hypogonadal men compared to placebo, and significantly enhanced levels of LH and FSH compared to T gel. The findings suggest that SERM therapy effectively increases TT levels in men with functional hypogonadism and should be considered as an alternative to T gel therapy.

PubMed 41066380 ↗
Andrology · 2023 · Meta-analysis / systematic review
Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis

Conclusion: Treatment with clomiphene citrate and enclomiphene citrate may be an effective and safe alternative to testosterone replacement therapy in men with obesity-related functional androgen deficiency. Further long-term studies are warranted to define clinical reflections of the selective estrogen receptor modulators-induced increase in testosterone levels and to better clarify the safety profile.

PubMed 36604313 ↗
Registered clinical trials

261 human trials on ClinicalTrials.gov test Enclomiphene — 161 completed, 9 recruiting now. See all on ClinicalTrials.gov ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

eye floaters ×9vision issues ×5mood swings ×4hair loss ×4blurry vision ×3fatigue ×2libido crash ×1erectile dysfunction ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I second Enclomiphene citrate. Been on 12.5mg per day sublingual pill and my test went from 430 to 950. No side effects other than being more horny.”
HelpedRead the discussion ↗
“Two months on Enclo. 12.5 g every day. Zero difference in energy levels/mood/libido. Will test my numbers next week. The only effect I can really feel is the shitload of eye floaters.”
MixedRead the discussion ↗
“Nothing much happened. I still had those problems after trying all that nootropics and supplements.”
Didn't helpRead the discussion ↗
“I felt like I was sleeping better, had more energy, more confidence, and more libido.”
MixedRead the discussion ↗
Read more Enclomiphene reviews →
Top discussions (5)

Enclomiphene compared

Other options for hormones

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate